Golden Helix Named to the 2019 Inc. 5000 List of Fastest-Growing Private Companies
August Newsletter
Golden Helix Named to the 2019 Inc. 5000 List of Fastest-Growing Private Companies

Golden Helix Named to the 2019 Inc. 5000 List of Fastest-Growing Private Companies
By Delaina Hawkins
Director of Marketing

Earlier this week, Inc. magazine ranked Golden Helix on the 2019 Inc. 5000 list with three-year revenue growth of 61%. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, and many other well-known names gained their first... Read More

Summer AMP Sale
Summer AMP Sale

We are offering a limited number of AMP-focused, 15-month license packs all summer long!

The individualized nature of tumors requires genomic testing for providing the best outcomes for patients. Next-Gen Sequencing enables the detection of small mutations, copy number changes, and common fusions affordably and with high precision. However, the interpretation of these detected variants is arduous without a comprehensive ... Read More
 Following the AMP Guidelines with VSClinical: Part I

Following the AMP Guidelines with VSClinical: Part I
By Gabe Rudy
VP of Product & Engineering

In the world of genomics shaping precision medicine in oncology, the limiting factor is the time-to-sign-out of a fully interpreted molecular profile report. There are many components of the entire testing process that add to the turn-around time of each test. Many of these steps, such as sample prep, sequencing, and automated secondary analysis, are bounded and consistent in their time requirements. The hands-on... Read More

Automating & Standardizing Your NGS Workflow

Automating & Standardizing Your NGS Workflow Blog Series
By Darby Kammeraad
Field Application Scientist Manager

This blog series will supply some insight into optimizing a full high throughput bioinformatics pipeline from FASTQ to clinical report. Our full software stack not only produces top quality variant calling and interpretation with our secondary and tertiary capabilities but also provides the means of storing your complete set of genomic data in VSWarehouse. Users can then leverage this collection of stored data against future samples to isolate rare variants... Read More

CEO Corner
New eBook: Clinical Variant Analysis for Cancer
We are honored to be apart of the Inc. 5000 which honors the top 5000 fastest-growing private companies in the US. Our traction in the clinical space has been tremendous, and as a result, our customer base has increased significantly creating substantial revenue growth that we're eternally grateful for. We thank our customers and partners for their loyalty to our brand and we look forward to continuing to earn your trust by providing innovative solutions and premium service.
Upcoming Webcast

Efficiently Following the AMP Guidelines with VSClinical and Golden Helix CancerKB 
September 11, 2019 | 12:00 PM Eastern

Interpreting somatic variants for the clinical genetic testing of tumors requires hands-on time of the most skilled clinical lab personnel. Various clinical and genomic sources must be queried, papers and guidelines referenced, and an evaluation of the clinical actionability of the mutation determined by the following the AMP guidelines. Yet, there is tremendous potential for reuse of this time consuming and valuable work!...

Customer Success

Our customers have published a number of fascinating articles throughout the summer! To highlight just a couple:

"Iranome: A catalogue of genomic variations in the Iranian population" - Mohammad Akbari & Colleagues, University of Toronto / Published in Human Mutation – Variation, Informatics and Disease

"Genomic approaches to identify hybrids and estimate admixture times in European wildcat populations" - Romolo Caniglia, Institute for Environmental Protection and Research (Italy), Leslie Lyons, University of Missouri (USA) & Colleagues / Published in Scientific Reports

Read more about the articles published over the summer on our blog!

About Golden Helix

Golden Helix has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years with 1,000s of users around the world. Their innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from NGS sequencers and microarrays. With their solutions, hundreds of the world's top hospitals, testing labs, pharmaceutical, biotech, and academic research organizations can harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.